Octopus AIM VCTs – capturing the growth potential of AIM along with all the tax incentives of a VCT
At Octopus we’re always looking for ways to help people do smarter things with their money. That’s why we’re a great believer in tax efficient investing. One of the advantages of VCTs for income-seeking investors is that they aim to pay out their profits to investors in the form of tax-free dividends.
We’re also a firm believer in the growth potential of the Alternative Investment Market (AIM), which has been helping exciting and innovative smaller companies thrive for almost two decades.
The Octopus AIM VCTs combine the tax incentives of a VCT with the opportunities of maturing smaller companies. The result? You have the potential for growth, delivered in the form of consistent dividend payments. The dividend payments made by the VCTs are tax free and can be used either to supplement or replace other investment income.
Although many VCTs focus on ‘early stage’ smaller companies, the Octopus AIM VCTs feature a large number of established, maturing AIM-listed companies. Many of the companies in both Octopus AIM VCTs have been listed on AIM for several years, and the majority of Octopus AIM VCT portfolio holdings are already delivering sales growth and generating profits*.
Octopus AIM VCTs are now closed for investment.
This advertisement is issued by Octopus Investments Ltd and is not a prospectus. Any decision to invest under the offer should be made solely on the basis of the information contained in the Prospectus and application forms which can be downloaded from the document library.
Here’s a summary of the key tax benefits:
- 30% income tax relief on up to £200,000 in a tax year (if shares are sold before the end of the five-year qualifying period then the tax relief will need to be paid back).
- No capital gains tax if you sell your VCT shares for a profit.
- Up to two tax-free dividends a year. The VCT has an annual dividend target, paid twice a year. For information about the dividend target, and history of dividend payment, please see our brochure.
What makes AIM attractive for VCT investors?
- High-quality smaller companies: the Octopus Smaller Companies team invests in market-leading businesses across many different industries, including building materials, technology development and medical devices.
- Greater transparency: AIM-listed companies must meet certain regulatory and governance requirements, ensuring higher levels of transparency than unquoted and early-stage businesses.
- Diversified portfolios: – there are more than 60 different sectors on AIM and plenty of companies to choose from. The Octopus Smaller Companies team invests in more than 60 companies across the two funds, so investors can be confident their investment will feature many of the brightest companies from AIM.
Key risks for investors to consider
Investments in smaller companies carry higher risks than larger company investments.
Your capital is at risk and you may not get back as much as you invested. VCT shares are likely to have higher volatility and liquidity risk than other types of shares quoted on the Main Market of the London Stock Exchange.
VCTs should be viewed as a long-term investment as shares need to be held for five years to qualify for tax reliefs. If an investor decides to sell their VCT shares at any point, they may not be able to find a buyer straightaway. AIM VCTs, however, intend to offer investors a buyback option. For more details, please see our brochure.
Tax treatment depends on the individual circumstances of each investor and may be subject to change. The availability of tax reliefs also depends on the companies a VCT invests in maintaining their qualifying status. HM Revenue & Customs may change the rules on VCT tax relief in the future.
Past performance is not a reliable indicator of future results and any forecast is not a reliable indicator of future performance.
Please also note that this advertisement is not a prospectus and investors should only subscribe for VCT shares on the basis of information in the relevant prospectus, which can be obtained from here.
*Source: Octopus. Date: August 2014.